-
Predictive value of chromosome 18q11.2-q12.1 loss for benefit from bevacizumab in metastatic colorectal cancer; a post-hoc analysis of the randomized controlled trial AGITG-MAX
Study
EGAS00001005453
-
Germline variants collaborate with somatic mutations and initiate and/or drive disease in primary myelodysplastic syndrome (MDS) and therapy-related myeloid neoplasms (t-MN)
Study
EGAS00001003547
-
Transdisciplinary Studies of Genetic Variation in Colorectal Cancer(CORECT): Meta-analysis
Study
phs001499
-
CIDR, NCI, NIDA Sequencing of Targeted Genomic Regions Associated with Smoking
Study
phs000813
-
ALCHEMIST Study
Study
phs001140
-
Integration of Clinical and Molecular Biomarkers for Melanoma Survival (Berwick)
Study
phs003099
-
Implementation of pediatric precision oncology into clinical practice: The individualized Therapies for Children with cancer program “iTHER”
Study
EGAS00001007099
-
Breast cancer DNA repair
Study
EGAS00001002792
-
Myeloma Genome Project Targeted Panel Validation dataset
Dataset
EGAD00001008689
-
Clonal selection after gene therapy in sickle cell disease
Dataset
EGAD00001010913
-
High-Resolution Clonal Mapping of Multi-Organ Metastasis, and Resistance to Neoadjuvant Chemotherapy, in Triple Negative Breast Cancer
Study
phs001742
-
Heterogeneity of IKZF1 genomic alterations and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia
Study
EGAS50000000106
-
Successful Clinical Response in Pneumonia Therapy (SCRIPT)
Study
phs002300
-
Alzheimer's Disease Sequencing Project (ADSP)
Study
phs000572
-
Intra-tumor heterogeneity and clonal evolution patterns towards platinum-resistant high-grade serous ovarian cancer
Study
EGAS00001001244
-
Analysis of RAD51C promoter methylation using targeted bisulfite sequencing (amplicon sequencing) in ovarian cancer pre-clinical models and patient samples.
Study
EGAS00001005395
-
Proteom characterization in primary colorectal cancer and corresponding liver metastasis
Study
EGAS00001005641
-
Biomarker Screen for Efficacy of Oncolytic Virotherapy in Patient-derived Pancreatic Cancer Cultures
Study
EGAS00001007001
-
Study of Melanoma Risk in Australia and the United Kingdom
Study
phs000519
-
Successful immune checkpoint blockade in a patient with advanced stage microsatellite unstable biliary tract cancer (H021)
Study
EGAS00001002441
-
Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells
Dataset
EGAD00001007029
-
The NCAA-DoD Concussion Assessment, Research, and Education (CARE) Consortium
Study
phs002175
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
eMERGE Network Phase III: HRC SNV and 1000 Genomes SV Imputed Array Data of 105,000 Participants
Study
phs001584
-
Research Program on Genes, Environment and Health (RPGEH)
Study
phs000788